Literature DB >> 9050870

Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population.

A J Brown1.   

Abstract

Selection is usually considered to be the dominant force controlling viral variation; the large population sizes suggest that deterministic population genetic models are appropriate. To investigate their validity for HIV, samples of env gene sequences were tested for departure from neutrality because of mutation-selection balance. None of the samples departed significantly when tested as nucleotide sequences. At the amino acid level, significantly elevated diversity was detected in two samples within, but not outside, the V3 loop. The effective population number has been estimated (using a phylogenetic method) to be close to 10(3). Estimates from nucleotide diversity are about 2-fold lower. The low value of the effective population number might arise from high variability in progeny number between infected cells, from the expansion in population number from a small inoculum as the virus is transmitted between hosts, or from variable selection at linked sites. These results suggest that the population genetics of HIV are best described by stochastic models.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9050870      PMCID: PMC20008          DOI: 10.1073/pnas.94.5.1862

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease.

Authors:  M A Nowak; R M May; R M Anderson
Journal:  AIDS       Date:  1990-11       Impact factor: 4.177

2.  A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160.

Authors:  H Takahashi; S Merli; S D Putney; R Houghten; B Moss; R N Germain; J A Berzofsky
Journal:  Science       Date:  1989-10-06       Impact factor: 47.728

3.  Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.

Authors:  F Tajima
Journal:  Genetics       Date:  1989-11       Impact factor: 4.562

4.  Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1.

Authors:  B T Korber; K MacInnes; R F Smith; G Myers
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.

Authors:  D D Ho; T Moudgil; M Alam
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

6.  Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous.

Authors:  T F Wolfs; J J de Jong; H Van den Berg; J M Tijnagel; W J Krone; J Goudsmit
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Plasma viremia in human immunodeficiency virus infection.

Authors:  R W Coombs; A C Collier; J P Allain; B Nikora; M Leuther; G F Gjerset; L Corey
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

8.  Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.

Authors:  B Chesebro; J Nishio; S Perryman; A Cann; W O'Brien; I S Chen; K Wehrly
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

Authors:  S S Hwang; T J Boyle; H K Lyerly; B R Cullen
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

10.  Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

Authors:  J R Rusche; K Javaherian; C McDanal; J Petro; D L Lynn; R Grimaila; A Langlois; R C Gallo; L O Arthur; P J Fischinger
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

View more
  89 in total

1.  The molecular clock of HIV-1 unveiled through analysis of a known transmission history.

Authors:  T Leitner; J Albert
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 2.  HIV evolutionary genetics.

Authors:  A G Rodrigo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

3.  Linkage disequilibrium test implies a large effective population number for HIV in vivo.

Authors:  I M Rouzine; J M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 4.  Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology.

Authors:  I M Rouzine; A Rodrigo; J M Coffin
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

5.  Structure and temporal dynamics of populations within wheat streak mosaic virus isolates.

Authors:  J S Hall; R French; T J Morris; D C Stenger
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Genetic drift and within-host metapopulation dynamics of HIV-1 infection.

Authors:  S D Frost; M J Dumaurier; S Wain-Hobson; A J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

7.  Assessing the effects of human mixing patterns on human immunodeficiency virus-1 interhost phylogenetics through social network simulation.

Authors:  Steven M Goodreau
Journal:  Genetics       Date:  2006-04       Impact factor: 4.562

Review 8.  Maximum likelihood methods for detecting adaptive evolution after gene duplication.

Authors:  Joseph P Bielawski; Ziheng Yang
Journal:  J Struct Funct Genomics       Date:  2003

9.  Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments.

Authors:  David C Nickle; Mark A Jensen; Daniel Shriner; Scott J Brodie; Lisa M Frenkel; John E Mittler; James I Mullins
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

10.  Dynamics of HIV-1 recombination in its natural target cells.

Authors:  David N Levy; Grace M Aldrovandi; Olaf Kutsch; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.